Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-17

Study Completion Date

2021-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thyroidectomy is considered a common operation with moderate to severe postoperative pain in some patients. Patients are divided into two groups. Bupivacaine group received bilateral superficial cervical plexus block (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of normal saline on each side and the Bupivacaine Ketorolac group received (BSCPB) with 10 ml of bupivacaine (0.25%) and 1 ml of ketorolac (15 mg) on each side.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.

NCT06633068

Intra and Postoperative Pain Management

RECRUITING PHASE2

Ketamine or Neostigmine for Serratus Anterior Plane Block in Modified Radical Mastectomy

NCT04544228

Postoperative Pain

COMPLETED NA

Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy

NCT01454609

Pain Postoperative

COMPLETED PHASE2

Ultrasound Guided Intermediate Cervical Plexus Block in Thyroid Surgery

NCT03731468

Postoperative Pain

COMPLETED NA

Superficial Cervical Plexus Block and Quality of Recovery After Thyroidectomy

NCT06002152

Postoperative Pain

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroid Goiter Thyroid Nodule

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

bupivacaine

Group Type ACTIVE_COMPARATOR

Bupivacain

Intervention Type DRUG

analgesic

bupivacaine and ketorolac

Group Type ACTIVE_COMPARATOR

Bupivacain

Intervention Type DRUG

analgesic

Ketorolac

Intervention Type DRUG

analgesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupivacain

analgesic

Intervention Type DRUG

Ketorolac

analgesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 20-50 years
* ASA I-II patients
* Patients going to do thyroid surgeries under general anesthesia

Exclusion Criteria

* Patient refusal
* Known history of sensitivity to the drug used in the study
* Drug abuse
* Infection at the site of the block
* Presence of coagulopathy

Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No